Myasthenia Gravis: Clinical and Immunological Aspects
Autoimmune diseases such as myasthenia gravis (MG) result from an altered balance between the processes of activation and regulation of immune response. MG is the most common autoimmune disorder characterized by failure of transmission at the neuromuscular junction (NMJ). Autoantibodies in MG target...
Saved in:
| Main Author: | |
|---|---|
| Format: | Ebooks |
| Published: |
IntechOpen,
2017-03-22.
|
| Subjects: | |
| Online Access: | Get Online |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Autoimmune diseases such as myasthenia gravis (MG) result from an altered balance between the processes of activation and regulation of immune response. MG is the most common autoimmune disorder characterized by failure of transmission at the neuromuscular junction (NMJ). Autoantibodies in MG target the acetylcholine receptors (AChRs) as well as non-AChR components like muscle-specific tyrosine kinase (MuSK). Autoantibodies against AChRs are produced by B cells in the germinal centres (GCs), formed in the medulla of MG thymus and circulated to the post-synaptic side of the neuromuscular junction (NMJ) leading to complement-mediated destruction of the post-synaptic folds of NMJ and internalization of AChRs. The incidence and prevalence of MG have increased particularly in elderly, but clinical presentations vary substantially and recognition depends on classic disease phenotype. This chapter focuses on clinical and immunological aspects of MG and its subgroups based on its characterization of the antigenic targets. |
|---|---|
| Item Description: | https://mts.intechopen.com/articles/show/title/myasthenia-gravis-clinical-and-immunological-aspects |